Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

Multidrug-resistant tuberculosis (MDR-TB) is a major threat to global TB control. MDR-TB treatment regimens typically last 20 months or more, require a patient to take a high number of pills, and often lead to unsatisfactory results. This research conclusively proves that a 9–11-month regimen with seven antibiotics can demonstrate high success rates among selected MDR-TB patients in different settings. It further states that greater gains may be possible in contexts where the regimen is more widely applicable.

Multidrug-resistant tuberculosis

Show Buttons
Share On Facebook
Share On Twitter
Share On Linkedin
Contact us
Hide Buttons